Artivion (AORT) Shares Outstanding (Diluted Average) (2009 - 2026)
Artivion (AORT) reported Shares Outstanding (Diluted Average) of $49.7 million for Q1 2026, up 17.76% on a YoY basis from $42.2 million in Q1 2025, and up 5.45% quarter-over-quarter from $47.2 million in Q4 2025.
Artivion (AORT) Shares Outstanding (Diluted Average) (2009 - 2026) Analysis & Trends
Artivion has reported Shares Outstanding (Diluted Average) for 11 years, with the latest figure at $49.7 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 17.76% year-over-year to $49.7 million; the trailing twelve-month figure through Mar 2026 stood at $49.7 million (up 17.76% YoY), and the FY2025 full-year result was $47.2 million, up 13.16% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $49.7 million, up from $47.2 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $49.7 million in Q1 2026, with the low at $39.8 million in Q1 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $42.9 million across 5 years, with a median of $41.7 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Diluted Average) rose 18.44% — and 2025, when it declined 11.81%.
- Artivion's Shares Outstanding (Diluted Average) stood at $40.0 million in 2022, then advanced by 1.78% to $40.7 million in 2023, then advanced by 2.29% to $41.7 million in 2024, then grew by 13.16% to $47.2 million in 2025, then gained by 5.45% to $49.7 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $49.7 million (Q1 2026), $47.2 million (Q4 2025), and $48.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Artivion | 1.02 Bn | 961.48 Mn | 75.45 Mn | 49.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.73 Mn |
| Dec 31, 2025 | 47.16 Mn |
| Sep 30, 2025 | 48.78 Mn |
| Jun 30, 2025 | 44.50 Mn |
| Mar 31, 2025 | 42.23 Mn |
| Dec 31, 2024 | 41.68 Mn |
| Sep 30, 2024 | 42.62 Mn |
| Jun 30, 2024 | 42.41 Mn |
| Mar 31, 2024 | 47.89 Mn |
| Dec 31, 2023 | 40.74 Mn |
| Sep 30, 2023 | 40.69 Mn |
| Jun 30, 2023 | 40.60 Mn |
| Mar 31, 2023 | 40.43 Mn |
| Dec 31, 2022 | 40.03 Mn |
| Sep 30, 2022 | 40.12 Mn |
| Jun 30, 2022 | 39.94 Mn |
| Mar 31, 2022 | 39.85 Mn |
| Dec 31, 2021 | 38.98 Mn |
| Sep 30, 2021 | 39.50 Mn |
| Jun 30, 2021 | 38.84 Mn |